Palvella Therapeutics Stock Forward View - Simple Regression
| PVLA Stock | 81.90 3.19 4.05% |
Palvella Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Palvella Therapeutics stock prices and determine the direction of Palvella Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Palvella Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time, the value of RSI of Palvella Therapeutics' share price is approaching 45 indicating that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Palvella Therapeutics, making its price go up or down. Momentum 45
Impartial
Oversold | Overbought |
Using Palvella Therapeutics hype-based prediction, you can estimate the value of Palvella Therapeutics from the perspective of Palvella Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Regression forecasted value of Palvella Therapeutics on the next trading day is expected to be 98.71 with a mean absolute deviation of 7.28 and the sum of the absolute errors of 444.09. Palvella Therapeutics after-hype prediction price | USD 81.9 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Palvella Therapeutics to cross-verify your projections. For information on how to trade Palvella Stock refer to our How to Trade Palvella Stock guide.Palvella Therapeutics Additional Predictive Modules
Most predictive techniques to examine Palvella price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Palvella using various technical indicators. When you analyze Palvella charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Palvella Therapeutics Simple Regression Price Forecast For the 31st of January
Given 90 days horizon, the Simple Regression forecasted value of Palvella Therapeutics on the next trading day is expected to be 98.71 with a mean absolute deviation of 7.28, mean absolute percentage error of 69.81, and the sum of the absolute errors of 444.09.Please note that although there have been many attempts to predict Palvella Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Palvella Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Palvella Therapeutics Stock Forecast Pattern
| Backtest Palvella Therapeutics | Palvella Therapeutics Price Prediction | Buy or Sell Advice |
Palvella Therapeutics Forecasted Value
In the context of forecasting Palvella Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Palvella Therapeutics' downside and upside margins for the forecasting period are 93.46 and 103.97, respectively. We have considered Palvella Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Palvella Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Palvella Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 122.3563 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 7.2802 |
| MAPE | Mean absolute percentage error | 0.0807 |
| SAE | Sum of the absolute errors | 444.0925 |
Predictive Modules for Palvella Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Palvella Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Palvella Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Palvella Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Palvella Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Palvella Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Palvella Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Palvella Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Palvella Therapeutics' historical news coverage. Palvella Therapeutics' after-hype downside and upside margins for the prediction period are 76.64 and 87.16, respectively. We have considered Palvella Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Palvella Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Palvella Therapeutics is based on 3 months time horizon.
Palvella Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Palvella Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Palvella Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Palvella Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.24 | 5.26 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
81.90 | 81.90 | 0.00 |
|
Palvella Therapeutics Hype Timeline
Palvella Therapeutics is at this time traded for 81.90. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Palvella is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is expected to be very small, whereas the daily expected return is at this time at 0.24%. %. The volatility of related hype on Palvella Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 81.90. About 21.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 2.92. Palvella Therapeutics had not issued any dividends in recent years. The entity had 1:80 split on the 23rd of April 2024. Given the investment horizon of 90 days the next expected press release will be within a week. Check out Historical Fundamental Analysis of Palvella Therapeutics to cross-verify your projections. For information on how to trade Palvella Stock refer to our How to Trade Palvella Stock guide.Palvella Therapeutics Related Hype Analysis
Having access to credible news sources related to Palvella Therapeutics' direct competition is more important than ever and may enhance your ability to predict Palvella Therapeutics' future price movements. Getting to know how Palvella Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Palvella Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GHRS | GH Research PLC | 0.00 | 0 per month | 3.86 | 0.07 | 6.75 | (7.30) | 40.50 | |
| SPRY | ARS Pharmaceuticals | 0.00 | 0 per month | 4.50 | 0.07 | 8.29 | (8.73) | 32.13 | |
| NBTX | Nanobiotix | 0.00 | 0 per month | 3.12 | 0.09 | 6.58 | (5.64) | 18.61 | |
| PROK | ProKidney Corp | 0.00 | 0 per month | 0.00 | (0.09) | 5.77 | (8.95) | 22.38 | |
| SVRA | Savara Inc | 0.00 | 0 per month | 2.97 | 0.11 | 8.25 | (4.98) | 24.50 | |
| KURA | Kura Oncology | 0.00 | 0 per month | 0.00 | (0.07) | 4.96 | (5.08) | 22.27 | |
| ABUS | Arbutus Biopharma Corp | 0.00 | 0 per month | 0.00 | (0.05) | 5.10 | (4.71) | 20.16 | |
| RZLT | Rezolute | 0.00 | 0 per month | 15.88 | 0.04 | 18.05 | (9.22) | 99.29 | |
| EYPT | Eyepoint Pharmaceuticals | 0.00 | 0 per month | 3.37 | 0.07 | 6.24 | (4.87) | 22.25 | |
| TYRA | Tyra Biosciences | 0.00 | 0 per month | 1.58 | 0.27 | 6.05 | (2.98) | 34.11 |
Other Forecasting Options for Palvella Therapeutics
For every potential investor in Palvella, whether a beginner or expert, Palvella Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Palvella Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Palvella. Basic forecasting techniques help filter out the noise by identifying Palvella Therapeutics' price trends.Palvella Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Palvella Therapeutics stock to make a market-neutral strategy. Peer analysis of Palvella Therapeutics could also be used in its relative valuation, which is a method of valuing Palvella Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Palvella Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Palvella Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Palvella Therapeutics shares will generate the highest return on investment. By undertsting and applying Palvella Therapeutics stock market strength indicators, traders can identify Palvella Therapeutics entry and exit signals to maximize returns.
Palvella Therapeutics Risk Indicators
The analysis of Palvella Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Palvella Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting palvella stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.11 | |||
| Semi Deviation | 4.68 | |||
| Standard Deviation | 5.26 | |||
| Variance | 27.63 | |||
| Downside Variance | 23.64 | |||
| Semi Variance | 21.87 | |||
| Expected Short fall | (4.56) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Palvella Therapeutics
The number of cover stories for Palvella Therapeutics depends on current market conditions and Palvella Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Palvella Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Palvella Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Palvella Therapeutics Short Properties
Palvella Therapeutics' future price predictability will typically decrease when Palvella Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Palvella Therapeutics often depends not only on the future outlook of the potential Palvella Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Palvella Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.2 M | |
| Cash And Short Term Investments | 83.6 M | |
| Shares Float | 6.6 M |
Check out Historical Fundamental Analysis of Palvella Therapeutics to cross-verify your projections. For information on how to trade Palvella Stock refer to our How to Trade Palvella Stock guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Palvella Therapeutics. Anticipated expansion of Palvella directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Palvella Therapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of Palvella Therapeutics is measured differently than its book value, which is the value of Palvella that is recorded on the company's balance sheet. Investors also form their own opinion of Palvella Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Palvella Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Palvella Therapeutics' market value can be influenced by many factors that don't directly affect Palvella Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Palvella Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Palvella Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Palvella Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.